Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Malaria High-Risk Populations in Namibia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04094727
Recruitment Status : Enrolling by invitation
First Posted : September 19, 2019
Last Update Posted : November 13, 2019
Sponsor:
Collaborators:
University of Namibia
Ministry of Health and Social Services, Namibia
University of Texas Southwestern Medical Center
University of Notre Dame
London School of Hygiene and Tropical Medicine
Information provided by (Responsible Party):
University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : May 31, 2020
Estimated Study Completion Date : May 31, 2020
Publications:
Initiative ME. Planning for targeted malaria interventions in high-risk populations (HRPs) in Northern Namibia: Findings from a rapid formative assessment in Zambezi Region. University of California, San Francisco, 2019.
The Global Health Group. Screen and treat strategies for malaria elimination: a review of evidence. 2018.
Malaria Elimination Initiative. Planning for targeted malaria interventions in high-risk populations (HRPs) in Northern Namibia: Findings from a rapid formative assessment in Ohangwena Region. University of California, San Francisco, 2019.
IOM (International Organization for Migration). A global report on population mobility and malaria: moving towards elimination with migration in mind. 2013.